Religare Enterprises Limited reported a consolidated net loss of ₹7,672.94 lakh for the quarter ended June 30, 2026, marking a significant shift from the net profit of ₹573.25 lakh recorded in the corresponding quarter of the previous fiscal year. The company’s standalone operations also incurred a loss, with the standalone net loss widening to ₹961.97 lakh from ₹614.83 lakh in Q1FY25.

The Board of Directors approved the unaudited standalone and consolidated financial results during a meeting held on August 12, 2026. The results were subsequently published on the stock exchanges on August 13, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Overview

Consolidated revenue from operations stood at ₹2,35,339.81 lakh for the quarter, up from ₹1,87,152.12 lakh in Q1FY25. Despite the growth in top-line figures, the bottom line deteriorated sharply, swinging from a profit to a substantial loss year-on-year.

On a standalone basis, total revenue from operations was ₹251.68 lakh, a significant increase from ₹24.01 lakh reported in the same period last year. However, this revenue did not translate into profitability, as the company continued to face operational headwinds.

What the Numbers Show

A notable divergence exists between the company’s comprehensive income and its net profit figures on a consolidated basis. While the consolidated net loss widened significantly to ₹7,672.94 lakh, the total comprehensive income remained positive at ₹2,712.04 lakh. This suggests that other comprehensive income items, such as revaluation gains or foreign currency translation adjustments, offset the operational losses for the period. In contrast, the standalone entity showed no such offset, with both net loss and comprehensive income remaining negative.

Share Capital and EPS

The paid-up equity share capital increased slightly to ₹34,123.37 lakh as of June 30, 2026, from ₹33,289.05 lakh at the end of FY26. Earnings per share (EPS) turned negative for the quarter. Basic and diluted EPS on a consolidated basis were (₹0.78), down from (₹0.31) in Q1FY25. On a standalone basis, basic and diluted EPS were (₹0.29), compared to (₹0.19) in the prior year quarter.

Religare Enterprises reported a consolidated net loss of ₹46.98 crore for the quarter ended June 30, 2026 (Q1FY27), narrowing significantly from a loss of ₹95.65 crore in the preceding quarter. This represents a substantial improvement from the ₹208 crore loss cited in earlier reports, aligning with the final unaudited financials presented to investors on August 12, 2026. Consolidated total income rose to ₹2,358.43 crore, up from ₹1,876.25 crore in Q1FY26, driven primarily by robust growth in the insurance segment.

The board approved the unaudited standalone financial results on August 12, 2026, following a limited review by statutory auditors J C Bhalla & Co. In its standalone segment, the company recorded a narrowed net loss of ₹9.62 crore for Q1FY27, compared to a loss of ₹12.37 crore in Q4FY26. Total income in the standalone segment rose to ₹4.38 crore, up from ₹3.35 crore in the prior quarter.

Financial Performance

Standalone revenue from operations increased to ₹2.52 crore from ₹1.72 crore in the previous quarter. Interest income rose slightly to ₹1.67 crore from ₹1.27 crore, while net gain on fair value changes remained stable at ₹0.30 crore. Other operating income grew to ₹0.55 crore from ₹0.45 crore.

Total standalone expenses declined to ₹14.00 crore from ₹15.72 crore. Employee benefits expense increased to ₹9.27 crore from ₹4.62 crore, while other expenses dropped sharply to ₹3.95 crore from ₹10.22 crore. Finance costs remained low at ₹0.23 crore.

Consolidated Segment Highlights

The investor presentation revealed that the Insurance segment contributed ₹2,229.74 crore to consolidated revenue, while Financial Services contributed ₹133.13 crore. The Insurance segment reported a segment performance loss of ₹87.26 crore, offset partially by a profit of ₹13.27 crore from Financial Services. Unallocated costs stood at ₹2.74 crore.

Care Health Insurance Ltd (CHIL), a key subsidiary, reported Gross Written Premium (GWP) of ₹3,247 crore in Q1FY27, registering a robust growth of ~37% year-on-year. CHIL raised ₹150 crore through a rights issue in Q1FY27 and ₹200 crore through Tier II capital in August 2026. Its investment book expanded to ₹11,751 crore, providing a gross debt yield of 7.3%.

Religare Broking Limited (RBL) saw a 7% year-on-year growth in total income to ₹99.5 crore, driven by a 13% increase in brokerage and a 28% rise in interest income. RBL’s profit after tax grew 65% year-on-year to ₹7.5 crore.

Capital Raise and Investments

During the quarter, Religare Enterprises converted share warrants into equity shares, receiving proceeds of ₹1,470.5 lakh. This conversion involved 83,43,263 shares allotted at a price of ₹235 per share. Consequently, the paid-up equity capital increased to ₹3,412.3 crore divided into 34,12,33,742 equity shares.

The company also subscribed to a rights issue amounting to ₹1,196.9 lakh in its subsidiary, Care Health Insurance Ltd. Cash and cash equivalents rose to ₹298.3 lakh from ₹210.0 lakh at the end of the previous quarter.

What the Numbers Show

The divergence between the initial reported consolidated loss of ₹208 crore and the final unaudited figure of ₹46.98 crore highlights significant adjustments in inter-company eliminations or subsidiary accounting treatments. While the standalone entity managed to narrow its loss by reducing other expenses, the consolidated result remains negative due to headwinds in the broader group operations, particularly within the insurance segment where high expense ratios persist despite strong premium growth.

Regulatory and Legal Updates

The company continues to face ongoing legal proceedings. It remains barred from declaring dividends as per an RBI letter issued in December 2019. Additionally, the Reserve Bank of India did not accede to the company’s request regarding a proposed demerger scheme with Religare Finvest Limited, issuing a communication on August 6, 2026. The company plans to engage further with the regulator to provide necessary clarifications.

Income tax litigation remains pending before the Income Tax Appellant Tribunal (ITAT). A rectification order reduced the tax demand to ₹1,085.3 lakh for the assessment year 2017-18. The company has obtained an interim stay on the recovery of this demand and views the chances of a favorable outcome as high.